Clinical Trials Directory

Trials / Completed

CompletedNCT01248091

The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion

The Effect of Nitroprusside on the IUD Insertion Experience in Nulliparous Women: a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Increasing accessibility of long-acting reversible contraceptive methods, like intrauterine devices (IUDs), is an important strategy to reduce the risk of unintended pregnancy. Unfortunately, fear of IUD insertion in women who have not had children is common among health care providers and women alike, and this limits IUD use. To increase acceptance of this highly effective contraceptive, there is need to investigate novel, low cost, easily applied and accessible techniques to improve the insertion experience. This is a pilot study to evaluate the efficacy and tolerability of nitroprusside gel applied intracervically as an intervention to improve the IUD insertion experience for both patient and provider.

Detailed description

Subjects who are have already scheduled an IUD insertion will be asked to join this study assessing whether or not nitroprusside gel helps with IUD insertion process. Only healthy, nulliparous women between the ages of 18 and 45 will be recruited. Nulliparous women report much more pain associated with IUD insertion than parous women so the possibility of being able to measure the effect of nitroprusside vs placebo is more likely. The primary outcome, pain with IUD insertion, and the secondary outcomes, such as satisfaction and provider ease of IUD insertion, will be compared between the study groups as well.

Conditions

Interventions

TypeNameDescription
PROCEDURENitroprusside Gel10 cc nitroprusside gel
PROCEDUREPlacebo Gelhalf of the subjects will receive nitroprusside gel for IUD insertion and the other half will receive a placebo gel.

Timeline

Start date
2010-12-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-11-25
Last updated
2012-09-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01248091. Inclusion in this directory is not an endorsement.